Pangen Biotech Inc.
Develops and manufactures biopharmaceuticals and offers CDMO services.
222110 | KO
Overview
Corporate Details
- ISIN(s):
- KR7222110009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 신원로 306, 2동 4층(원천동 영통이노플렉스) , 수원시
- Sector:
- Manufacturing
Description
Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-07 00:00 |
감사보고서제출
|
Korean | 17.1 KB | ||
| 2022-03-04 00:00 |
주주총회소집결의
|
Korean | 14.4 KB | ||
| 2022-02-22 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2022-02-21 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 25.8 KB | ||
| 2022-02-21 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 96.7 KB | ||
| 2022-01-03 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB | ||
| 2021-12-29 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 12.5 KB | ||
| 2021-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2021-11-22 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 96.1 KB | ||
| 2021-11-22 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 25.3 KB | ||
| 2021-11-18 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2021-11-12 00:00 |
분기보고서 (2021.09)
|
Korean | 1.0 MB | ||
| 2021-09-30 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 21.0 KB | ||
| 2021-09-17 00:00 |
투자판단관련주요경영사항(A형 혈우병 치료제 PGA40의 다국가 임상3상시험 계획변경 승인)
|
Korean | 11.1 KB | ||
| 2021-09-16 00:00 |
기타경영사항(특허권취득)(자율공시)(항-혈액응고 제Ⅷ인자 항체 및 그 용도)
|
Korean | 5.0 KB |
Automate Your Workflow. Get a real-time feed of all Pangen Biotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pangen Biotech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pangen Biotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
